Peptic ulcer and its complications in Ancient Mesopotamian Cuneiform Texts

Peptic ulcer and its complications in Ancient Mesopotamian Cuneiform Texts

While the earliest known records on the digestive system were made by Hippocrates in 400 BC, the first description of peptic ulcer was made by Marcellus Donatus in 1586. However, when the cuneiform texts of Ancient Mesopotamia, which provide information on medical subjects, are examined, records of many diseases draw attention. Peptic ulcer is one of the important diseases that draws attention in the medical records of Ancient Mesopotamian societies, especially in the Sakikku series obtained from the Asurbanipal Library. This study is based on the information obtained by comparing the cuneiform documents with the current medical literature. The aim of the study is to reveal that the findings of peptic ulcer disease were recorded earlier than Hippocrates. In 10 of the 11 cuneiform texts analyzed in this study, there is information about epigastric pain, the most prominent symptom of peptic ulcer. Words meaning peptic ulcer are found in 6 texts (Sumerian A.GA.ZI 2, Akkadian tugānu 4) (54.5%). In 3 texts, if bloody vomiting continues, death is stated as the prognosis. The term "gastroduodenal disease" in relation to the gastroduodenal resultant, where obstruction and bleeding are common, occurs in 5 texts. In 4 of them (tugānu 3, A.GA.ZI 1), peptic ulcer disease is mentioned (80%). In 4 texts in which "gastric outlet disease" and "peptic ulcer disease" are mentioned together, vomiting also accompanies the disease. Additionally, since the concrete symptoms of peptic ulcer could be identified, the cause of the disease was not attributed to abstract concepts such as devil, evil spirit, and demon in the related texts.

___

  • 1. Kramer SN. Tarih Sümer’de Başlar. 4th ed. Hamide Koyukan (trans.). İstanbul: Kabalcı Yayıncılık; 2021.
  • 2. Bottéro J. Babil’de Sihir ve Tıp, Eski Yakındoğu Sümer’den Kutsal Kitap’a. Adnan K, Pınar G, Lale AÖ (trans.). Ankara: Dost Kitapevi; 2005.
  • 3. Scurlock J, Andersen BR. Diagnoses in Assyrian and Babylonian Medicine. Ancient Sources, Translations, and Modern Medical Analyses. Urbana-Chicago: University of Illinois Press; 2005.
  • 4. Kaçar A. Eski Mezopotomya'da Büyü ve Büyücülük. Doktora Tezi: T.C. Ankara Üniversitesi Sosyal Bilimler Enstitüsü Tarih (Eskiçağ Tarihi) Anabilim Dalı; 2020.
  • 5. Mieroop MVD. Antik Yunan’dan Önce Felsefe. İstanbul: Ketebe Yayınları; 2020.
  • 6. Erdem F. Eski Mezopotamya'da Kehanet Geleneği. Doktora Tezi; Pamukkale Üniversitesi Sosyal Bilimler Enstitüsü Tarih Anabilim Dalı; 2020.
  • 7. Diri B. Eski Mezopotamya’daki Hastalıkların Modern Tıpla İlişkisi (Gastoenteroloji, Nöroloji, Psikiyatri, Enfeksiyon Hastalıkları). Yüksek Lisans Tezi: Ondokuz Mayıs Üniversitesi Sosyal Bilimler Enstitüsü Tarih Anabilim Dalı; 2022.
  • 8. Wilson JK. Babil'de Hastalıklar: Örnek Metinlere Dayalı Bir İnceleme. Gökhan K (trans.). Tarih İncelemeleri Dergisi. 2008; XXIII(2): 261-274.
  • 9. Aydın N. Büyük Sümerce Sözlük. Ankara: Türk Dil Kurumu Yayınları; 2013.
  • 10. Gurney OR, Finkelstein JJ, The Sultantepe Tablets (STT), Occasional Publications of the British Institute of Archaeology at Ankara 3 and 7. London: British Institute of Archaeology at Ankara; 1957, 1964. (STT 96:9-10; STT 96:5; STT 96:20-21;STT 96: 9-10).
  • 11. Thompson, R. C. Assyrian Medical Texts from the Originals in the British Museum (AMT). London: Oxford University Press; 1923. (AMT 48/2:1-3).
  • 12. Oviedo JA, Wolfe MM. Mide ve Duodenum Hastalıkları. Hatice K (trans.). In: Andreoli C, Charles CJ, Griggs RC, Benjamin IJ editors, Doç.Dr. Selçuk M (trans.). CECIL essentials of MEDICINE (Türkçe) 7'nci Edisyon, Ankara: Nobel Tıp Kitapevi; 2008, p. 390-405.
  • 13. Kocher F. Die babylonisch-assyrische Medizin in Texten und Untersuchungen (BAM), Vol. 1-6. Berlin and New York: Walter de Gruyter; 1963-80. (BAM 75:l-2; BAM 578 ii 20-21; BAM 75:5-99).
  • 14. Labat R. Traiti Akkadien de Diagnostic et de Pronostic Midicaux-2. Paris: Académie Internationale D’histoire des Sciences; 1952. (TDP 114: i 40 '; DPS XIII B i 36' - TDP 114: i 40 '; DPS XIIIB i 38'=TDP114 i 42'; DPS XIIIB i 39' =TDP 114i 43 ').
  • 15. Yazıcı A. Peptik Ülser Hastalığı Değişiyor. Tıpta Uzmanlık Tezi: T.C İstanbul Üniversitesi Tıp Fakültesi Aile Hekimliği Anabilimdalı; 2008.
  • 16. Kılıcarslan H, Kalyon S,Yenice N. Peptik Ülser Etyopatogenez. Okmeydanı Tıp Dergisi. 2013; 27(2): 65–69. https://doi.org/10.5222/otd.2011.065.
  • 17. Ogilvie H, KBE, M Ch, FRCS. A Hundred Years of Gastric Surgery. 11 Temmuz 1947’de Atlantic City'deki Amerikan Tabipler Birliği'nin Yüzüncü Yıl Toplantısı'nda yapılan konuşmanın genişletilmiş versiyonu. 1947: 37-50.
  • 18. Graham DY. History of Helicobacter pylori, duodenal ulcer, gastric ulcer and gastric cancer. World J Gastroenterol. 2014; 20(18): 5191–5204. https://doi.org/10.3748/wjg.v20.i18.5191.
  • 19. Cheng TO. Glimpses of the past from the recently unearthed ancient corpses in China. Ann Intern Med. 1984; 101(5): 714–715. https://doi.org/10.7326/0003-4819-101-5-714
  • 20. Göral PD. Günümüzde ve Gelecekte Peptik Ülser Tedavisi. Güncel Gastroenteroloji. 2003; 115-119.
  • 21. Atan Y, Bahşi İ, Tataroğlu Z, Orhan M, Çetkin M. Dr. Charles Ambroise Bernard: Türkiyede Adli Otopsinin Başlangıcı. Adnan Menderes Üniversitesi Sağlık Bilimleri Fakültesi Dergisi, 2018; 2(3): 155-158.
Journal of Experimental and Clinical Medicine-Cover
  • Yayın Aralığı: 5
  • Başlangıç: 1980
  • Yayıncı: Ondokuz mayıs Üniversitesi Tıp Fakültesi
Sayıdaki Diğer Makaleler

Comparison of Lower Extremity Lymphedema Patients and Healthy Individuals with Plantar Pressure Sense, Balance, and Fall Risk: A Pilot Study

Duygu KORKEM YORULMAZ, Büşra PEHLİVAN, Tezel YILDIRIM ŞAHAN

Which one to choose for anti-cytokeratin immunohistochemistry in small gastric biopsies: Bleached Periodic acid schiff- Alcian blue (PAB) or May Grunwald Giemsa (MGG) sections?

Yasemen ADALI, Hatice BEŞEREN

The clinical features and concomitant diseases in preschool high myopia

Leyla NİYAZ ŞAHİN, Ayşe İdil ÇAKMAK, Özlem TERZİ, İnci GÜNGÖR

Disease Severity and Serum Endocan Levels in Fibromyalgia Patients

Nevsun PIHTILI TAŞ, Pinar ÖNER, Rabia AYDOGAN BAYKARA, Özlem AYTAÇ, Feray Ferda ŞENOL

Evaluation of the relationship between functional low back pain level and urinary incontinence severity

İzzet FİDANCI, Hilal AKSOY, Duygu AYHAN BAŞER

Maternal and perinatal outcomes of SARS-COV-2 Infection in Vaccinated Compared with Unvaccinated Pregnant Patients

Sevtap SEYFETTİNOĞLU, Cevdet ADIGÜZEL, Sevda BAŞ, Sefa ARLIER, Şevki Göksun GÖKULU, Mehmet NARİN, Raziye NARİN

Utility of preoperative neutrophil–lymphocyte and platelet–lymphocyte ratios in differential diagnosis of benign, borderline, and malignant ovarian tumors

Sahra Sultan KARA, Esra KELES, Derya SİVRİ AYDIN, Emre MAT, Gazi YILDIZ, Rezzan Berna TEMOÇİN, Pınar BİROL, Pınar YILDIZ

Investigation of Presence of O25b-ST131 Clone and in vitro Efficacy of Temocillin in Escherichia coli Isolates

Kübra HACIEMİNOĞLU ÜLKER, Dilara SOLMAZ, Kenza HAMRAOUİ, Huda ALKARKHI, Geys OMAR, Ahmed SADEK, Hamza ABDULSATTAR ABDULSATTAR, Yeliz TANRIVERDİ ÇAYCI

Diagnosing Hyper-IgE Syndrome in adulthood: A case based discussion in resource-limited setting

Deshinta Putri MULYA, Benedreky LEO, Doni Priambodo WİJİSAKSONO, Neneng RATNASARİ, Mohammad JUFFRİE

Investigation of the Relationship between Clinical Severity of Acne and Inflammatory Parameters in Patients with Acne Vulgaris

Hanife Merve AKÇA, Kevser TUNCER KARA